Senior author of Cadence’s latest manuscript in the Journal of Cardiac Failure, Duke University’s Dr. Marat Fudim, shares his insights on the positive impact these newly reported clinical outcomes could have on heart failure patients' health and cost of care. These results demonstrate that broader adoption of comprehensive RPM and centralized medication titration will close care gaps, enhance outcomes, and reduce costs. Learn more from Dr. Fudim below and read about it in Fierce Healthcare here: https://lnkd.in/exh3P-KY
⭕ #Heart_Failure has a massive impact on our society and the health care system. We as a system are unable to keep up with the increasing number of patients and the morbidity associated with this disease❗ 🔔 What would happen when #Heart_Failure care is "outsourced" to help with medication titration, follow up and prevention of HF hospitalizations? ❗ We now have such data In follow up: There were decreases in systolic blood pressure -7 and ⬆ in HF meds Did the additionally delivered care cost more money? No, 52% ⬇ in total cost of care (-$1,076.64 per patient/month) despite increase in $ due to PCP visits. Most $ savings were due to ⬇ in hospital and post discharge (ie. skilled nursing facility) related spending Hfsa Inc Rob Mentz Anuradha (Anu) Lala-Trindade (Lala) David I. Feldman Duke University Health System Cadence Ryan Tedford American Heart Association #JCF https://lnkd.in/eYeKp3Nq